Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
BCTXL
BRIACELL THERAPEUTICS CORP.
NASDAQ
$1.14
▲ UP 11.76% (0.12)

KEY STATISTICS

Market Cap$9.92 M
52w High$1.15
52w Low$0.88
Dividend Yield—
Frequency—
P/E-0.09
Volume8.32K
Shares Out.8.70M

COMPANY

LEADERSHIP

William V. Williams
CHIEF EXECUTIVE
William V. Williams

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 14, 2026
FULL TIME EMPLOYEES
17

PRICE

$1.14 ▲ UP 11.76% (+$0.12)
$1.00$1.05$1.10$1.1510:06 AM11:05 AM12:04 PM1:02 PM2:01 PM3:00 PM3:59 PM1.14

About BriaCell Therapeutics Corp.

https://briacell.com ↗

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

INDUSTRY

Biotechnology